|
Managing Director, Perseus-Soros BioPharmaceutical Fund, LP. Mr. Elms serves as a Managing Director of the Perseus-Soros BioPharmaceutical Fund, L.P. For five years prior to joining Perseus-Soros, Mr. Elms was a Principal in the Life Science Investment Banking group of Hambrecht & Quist (now J.P. Morgan H&Q). During his five years at H&Q, Mr. Elms was involved in over 60 financing and M&A transactions, helping clients raise in excess of $3.3 billion of capital. Mr. Elms’ primary areas of focus were the genomics and drug discovery technology sectors. Prior to H&Q, he traded mortgage-backed securities for two years at Donaldson, Lufkin & Jenrette. His previous healthcare sector experience includes over two years as a pharmaceutical sales representative for Marion Laboratories and two years as a consultant for The Wilkerson Group. Steve Elms serves as director of MAP Pharmaceuticals, Inc. and a number of private companies. | 